# Yangtze River Pharmaceutical (Group) Co., Ltd. – FDA Inspection, Jun 28, 2024

Source: https://www.keypedia.com/records/fda_inspections/yangtze-river-pharmaceutical-group-co-ltd/da4b7721-b28a-4ad2-a29b-b86ab8d79664
Source feed: FDA_Inspections

> FDA inspection 1245074 of Yangtze River Pharmaceutical (Group) Co., Ltd., June 28, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1245074
- Company Name: Yangtze River Pharmaceutical (Group) Co., Ltd.
- Inspection Date: 2024-06-28
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)

Company: https://www.keypedia.com/companies/yangtze-river-pharmaceutical-group-co-ltd/4758b09d-0a30-4746-b0e0-a55f6d216919

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8